MAPK1 and cancer: An equivalent mutation was isolated in another screen in yeast designed for identifying Fus3 molecules that are not inhibited by Hog1 [107], in a large-scale screen performed in mammalian cells for gain-of-function and inhibitor-resistant Erk2 mutants (D319 in Erk2) [95], and in cancer patients.